EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Papillary Thyroid Carcinoma: Correlation Between Molecular and Clinical Features

Qiang Wang, Bo Yu iD, Shuilong Zhang, Dongliang Wang, Zhifu Xiao, Hongjing Meng, Lingxiang Dong, Yuhang Zhang, Jie Wu, Zebin Hou, Yunji Zhu, Dewei Li

Molecular Diagnosis & Therapy · 2024

DOI: 10.1007/s40291-024-00721-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Diagnosis & Therapy, 2024. Verfasst von Qiang Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid Surgery, Shanxi Provincial People's Hospital, No. 29, Shuangta East Street, Yingze District, Taiyuan, 030012, Shanxi, China. Hauptthemen laut MEDLINE: Thyroid Cancer, Papillary, Proto-Oncogene Proteins B-raf, Mutation, Thyroid Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Thyroid cancer is prevalent worldwide, including in China, where its incidence is on the rise. Papillary thyroid carcinoma (PTC) is the predominant subtype. Investigating the relationship between clinical data associated with PTC and gene mutations is crucial for improving detection and treatment. PATIENTS AND METHODS: We collected samples and associated clinical data from 700 PTC patients at Shanxi Provincial People's Hospital. Using a panel of 57 genes linked to thyroid cancer, we sequenced the samples to determine the mutation frequency of thyroid cancer-associated genes in PTC. We further analyzed the correlation between gene variants and clinical information. RESULTS: The mean age of patients in this study was 42.5 years. Females predominated, comprising 507 of the total patient population, resulting in a female-to-male ratio of 2.63 (507:193). Tumor distribution revealed 198, 257, and 142 cases on the left, right, and both sides, respectively. Among the 57 thyroid cancer-related genes analyzed, we identified at least one driver gene in 83.6% of patients. Notably, 76.4% had BRAF mutations, mainly BRAFV600E, which constituted 90.9% of all BRAF mutations, with 535 cases exhibiting these mutations. Other significant driver genes included CHEK2 (n = 84), RET (n = 42), PIK3CA (n = 7), and EGFR (n = 7). RET fusions (n = 28) were also identified. Notably, patients under 55 years old exhibit a higher tendency towards advanced N staging, suggesting that younger individuals may be more prone to lymph node metastasis. Additionally, male patients were more likely to have advanced N stages. Importantly, a positive correlation was observed between higher BRAF allele frequencies and more advanced T and N stages. Similarly, correlation analysis revealed that a greater frequency of RET fusions correlated with later T and N stages. CONCLUSION: This study uncovered several significant insights. Younger PTC patients exhibited a higher propensity for lymph node metastasis. An elevated mutation frequency of BRAF was correlated with a higher occurrence of RET fusions, predisposing individuals to lymph node metastasis and potentially indicating a poorer prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid Cancer, PapillaryProto-Oncogene Proteins B-rafMutationThyroid NeoplasmsHumansMaleFemaleAdultMiddle AgedAgedProto-Oncogene Proteins c-retBiomarkers, TumorYoung AdultClass I Phosphatidylinositol 3-KinasesChinaCheckpoint Kinase 2Adolescent

Substanzen

Proto-Oncogene Proteins B-rafBRAF protein, humanProto-Oncogene Proteins c-retRET protein, humanBiomarkers, TumorClass I Phosphatidylinositol 3-KinasesCheckpoint Kinase 2CHEK2 protein, human

Autor:innen und Institutionen

  • Department of Thyroid Surgery, Shanxi Provincial People's Hospital, No. 29, Shuangta East Street, Yingze District, Taiyuan, 030012, Shanxi, China.
  • Department of Medicine, Beijing USCI Medical Laboratory, Beijing, 100195, China.
  • Department of Thyroid Surgery, Shanxi Provincial People's Hospital, No. 29, Shuangta East Street, Yingze District, Taiyuan, 030012, Shanxi, China. sxsyldw@163.com.

ORCID-Profile: Bo Yu

Zitieren

APA

Wang, Q., Yu, B., Zhang, S., Wang, D., Xiao, Z., Meng, H., Dong, L., Zhang, Y., Wu, J., Hou, Z., Zhu, Y., & Li, D. (2024). Papillary Thyroid Carcinoma: Correlation Between Molecular and Clinical Features. Molecular Diagnosis & Therapy. https://doi.org/10.1007/s40291-024-00721-1

Vancouver

Wang Q, Yu B, Zhang S, Wang D, Xiao Z, Meng H, et al. Papillary Thyroid Carcinoma: Correlation Between Molecular and Clinical Features. Molecular Diagnosis & Therapy. 2024. doi:10.1007/s40291-024-00721-1

BibTeX
@article{Wang2024,
  author = {Wang, Qiang and Yu, Bo and Zhang, Shuilong and Wang, Dongliang and Xiao, Zhifu and Meng, Hongjing and Dong, Lingxiang and Zhang, Yuhang and Wu, Jie and Hou, Zebin and Zhu, Yunji and Li, Dewei},
  title = {Papillary Thyroid Carcinoma: Correlation Between Molecular and Clinical Features},
  journal = {Molecular Diagnosis & Therapy},
  year = {2024},
  doi = {10.1007/s40291-024-00721-1}
}
Kostenlos starten →